RHYTHM Biosciences Ltd Cash Flow Conversion Efficiency

Latest as of December 2025: -1.037x

RHYTHM Biosciences Ltd cash flow conversion efficiency. Based on the latest financial reports, RHYTHM Biosciences Ltd (RHY) has a cash flow conversion efficiency ratio of -1.037x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-2.22 Million ≈ $-1.57 Million USD) by net assets (AU$2.14 Million ≈ $1.52 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of RHYTHM Biosciences Ltd (2017–2025)

Cash flow conversion efficiency of RHYTHM Biosciences Ltd from 2017 to 2025. This chart illustrates how RHYTHM Biosciences Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View RHYTHM Biosciences Ltd stock quote for real-time trading data and today's change.

RHYTHM Biosciences Ltd Cash Flow Conversion Ratio Explained

RHYTHM Biosciences Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

RHYTHM Biosciences Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of RHYTHM Biosciences Ltd ranked by their cash flow conversion efficiency. Also see RHYTHM Biosciences Ltd (RHY) total market value for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Lion Forest Industries Bhd KLSE:8486	-0.011x
Everest Metals Corporation Ltd AU:EMC	0.027x
CANADIAN NORTH RESOURCES F:EO0	0.006x
Veris Ltd AU:VRS	0.175x
UMS-Neiken Group Bhd KLSE:7227	-0.009x
Vulcan Infrastructure and Power Inc. NASDAQ:VIP	0.076x
88 Energy Ltd AU:88E	-0.020x
Builders Capital Mortgage Corp V:BCF	N/A

Annual Cash Flow Conversion Efficiency for RHYTHM Biosciences Ltd (2017–2025)

The table below shows the annual cash flow conversion efficiency of RHYTHM Biosciences Ltd from 2017 to 2025. Review RHY FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$659.89K ≈ $466.92K	AU$-2.92 Million ≈ $-2.07 Million	-4.427x	+37.45%
2024-06-30	AU$867.17K ≈ $613.58K	AU$-6.14 Million ≈ $-4.34 Million	-7.077x	-497.55%
2023-06-30	AU$5.87 Million ≈ $4.16 Million	AU$-6.96 Million ≈ $-4.92 Million	-1.184x	-40.49%
2022-06-30	AU$7.37 Million ≈ $5.22 Million	AU$-6.21 Million ≈ $-4.40 Million	-0.843x	+73.37%
2021-06-30	AU$1.71 Million ≈ $1.21 Million	AU$-5.40 Million ≈ $-3.82 Million	-3.165x	-112.71%
2020-06-30	AU$1.84 Million ≈ $1.30 Million	AU$-2.74 Million ≈ $-1.94 Million	-1.488x	-195.92%
2019-06-30	AU$5.85 Million ≈ $4.14 Million	AU$-2.94 Million ≈ $-2.08 Million	-0.503x	-152.79%
2018-06-30	AU$8.30 Million ≈ $5.87 Million	AU$-1.65 Million ≈ $-1.17 Million	-0.199x	-2177166.56%
2017-06-30	AU$1.42 Million ≈ $1.01 Million	AU$-13.00 ≈ $-9.20	0.000x	--

About RHYTHM Biosciences Ltd

AU:RHY Australia Diagnostics & Research

Market Cap

$16.01 Million

AU$22.63 Million AUD

Market Cap Rank

#25631 Global

#1101 in Australia

Share Price

AU$0.07

Change (1 day)

+0.00%

52-Week Range

AU$0.06 - AU$0.26

All Time High

AU$2.00